A brand new tiny insulin pump shall be coming to America soon.

Tandem Diabetes Care has announced that they’ve won FDA approval for the Mobi, their newest insulin pump. They call it the “world’s smallest durable insulin delivery system.”

The Tandem Mobi shall be about half the scale of the favored t:slim X2 pump.

Even though it is a tubed pump, the Mobi is sufficiently small to be worn in an “adhesive sleeve” that attaches to the body. Combined with an optional 5-inch tube, the Mobi seems like it would give the tubeless Omnipod 5 a run for its money. It may possibly even be clipped to the belt or slipped right into a pocket, like a standard insulin pump, and is sufficiently small to slip into the coin pocket of a pair of jeans.

More details — the Tandem Mobi:

• Employs Control-IQ, the favored automated insulin dosing algorithm available with Tandem’s t:slim X2.
• Holds 200 units of insulin, despite its small size.
• Can be fully controlled with an iPhone — there is no such thing as a screen on the pump, though there may be a bolus button to deliver insulin without using the smartphone.
• Is compatible with all of Tandem’s detachable infusion sets.
• Recharges cordlessly, with inductive charging.
• Is waterproof as much as an IP28 standard, “tested at 8 feet for two hours.”

The Mobi shall be indicated for individuals with diabetes over the age of 5.

As for timing, Tandem states that “A limited release of Tandem Mobi is anticipated to start out in late 2023 with full business availability planned in early 2024.” You’ll be able to join for updates at Tandem’s official site.